Clinical Trials for BioXcel Therapeutics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: BioXcel Therapeutics

Clinical Trials (6)

NCT06335407
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
PHASE1Not yet recruiting
10 participants
Started: Jul 28, 2025 · Completed: Oct 29, 2025
2 conditions7 sponsors1 location
NCT07116694
Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder
PHASE2Active, not recruiting
30 participants
Started: Jun 19, 2025 · Completed: Oct 31, 2025
6 conditions2 sponsors5 locations
NCT05558982
BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
PHASE2Active, not recruiting
22 participants
Started: Aug 16, 2023 · Completed: Nov 30, 2027
1 condition3 sponsors3 locations
NCT06093451
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
PHASE4Recruiting
32 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2024
4 conditions2 sponsors1 location
NCT05712707
Sublingual Dexmedetomidine for Treating Opioid Withdrawal
PHASE1/PHASE2Active, not recruiting
160 participants
Started: Feb 28, 2023 · Completed: Nov 30, 2025
2 conditions6 sponsors4 locations
NCT05025605
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
PHASE1Recruiting
140 participants
Started: Aug 27, 2021 · Completed: Dec 31, 2026
5 conditions2 sponsors5 locations